Global Clinical Chemistry Market, By Product Type (Clinical Chemistry Analysers, POC Test Kits, Clinical Chemistry Analyser Kits and Reagents), Application (Basic Metabolite Panel, Liver Function Test, Electrolyte Panel, Kidney Function Test, Lipid Profile, Specialty Chemical Test, Thyroid Profile, Other Biochemical Tests), End-User (Hospitals, Pathology Laboratories, Maternity Centres, Outpatient Centres, Clinics)– Industry Trends and Forecast to 2029
Market Analysis and Size
Clinical chemistry analyzers have been increasingly popular in recent decades as a result of major technological breakthroughs and expanding healthcare business demands. Clinical chemistry focuses on the examination of internal body fluids and provides precise diagnostic information. Modern clinical chemistry is built on the foundation of traditional manual laboratory tests. However, as technology has progressed, testing methods have developed, and various tests may now be performed in automated laboratories utilizing complex devices such as chemical analyzers.
Data Bridge Market Research analyses that the clinical chemistry market which was USD 13 billion in 2021, would rocket up to USD 19.58 billion by 2029, and is expected to undergo a CAGR of 5.25% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Clinical Chemistry Analysers, POC Test Kits, Clinical Chemistry Analyser Kits and Reagents), Application (Basic Metabolite Panel, Liver Function Test, Electrolyte Panel, Kidney Function Test, Lipid Profile, Specialty Chemical Test, Thyroid Profile, Other Biochemical Tests), End-User (Hospitals, Pathology Laboratories, Maternity Centres, Outpatient Centres, Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (US), Danaher (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (US), Siemens (Germany), ELI Tech Group (France), HORIBA, Ltd. (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (UK), Ortho Clinical Diagnostics (US), Nova Biomedical (US), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress Hauser Management AG (Switzerland), Diatron (Hungary), SFRI. (France), EKF and Medica Corporation (UK)
|
|
Market Opportunities
|
|
Market Definition
Chemical techniques are used in clinical chemistry to determine the amounts of chemical components in body fluids. It is a branch of biochemistry that deals with the diagnostic evaluation of bodily fluids. Clinical chemistry is used to diagnose diseases, determine metabolic function, and assess the presence of medications by evaluating serum, blood, cerebrospinal fluids, plasma, and urine samples for analyte concentration.
Clinical Chemistry Market Dynamics
Drivers
- Rise in demand of clinical chemistry
In the forecast period of 2022-2029, rising demand for POCT kits and analysers for rapid detection, rising occurrences of cardiovascular disorders, diabetes, hypertension, and others, rising preferences for automated devices, and increasing government initiatives for the prevalence of better healthcare diagnostics facilities are expected to accelerate the growth of the clinical chemistry market. On the other hand, the growing number of research activities will enhance numerous prospects, resulting in the clinical chemistry market growing during the projection period.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising healthcare spending, and the fast-growing diagnostic industry drive the worldwide clinical chemistry market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the clinical chemistry market forward.
- Prevalence of chronic ailments
The rise of clinical chemistry has recently been fueled by an increase in the frequency of chronic diseases such as cancer and diabetes, which has resulted in increased demand for faster diagnosis, technological innovations, and scientific research for future therapeutic applications. The developments give benefits such as easy parameter monitoring, automatic data gathering, and automatic variable modifications, to name a few. The whole clinical chemistry market is expected to rise in the future as healthcare and medical professionals need more automated clinical chemistry procedures. In addition, the clinical chemistry business is seeing growing demand due to rising disposable incomes and increased awareness of the need of diagnostic examinations.
Opportunities
The total clinical chemistry market is predicted to grow in the future due to an increased desire for automated clinical chemistry techniques among healthcare and medical professionals. In the coming years, government initiatives and actions to promote clinical chemistry's benefits could potentially help boost the clinical chemistry industry. Growing awareness of the importance of diagnostic tests and rising disposable incomes are driving demand in the clinical chemistry industry.
Restraints/Challenges
Unavailability of skilled professionals along with high cost of devices will hamper the growth of the clinical chemistry market in the mentioned forecast period.
This clinical chemistry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Clinical Chemistry Market
The COVID-19 epidemic had a negative impact on the companies' sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests performed and reagent sales. However, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. With the COVID-19 pandemic, dealing with infectious diseases has become a major medical concern around the world. In addition to vaccinations and therapeutic medications, there is an increasing demand for more precise and simple testing technologies as well as the expansion of testing structures.
Recent Development
- January 2019 – Hofmann-La-Roche Ltd has released COBAS PRO, an integrated solution in the Serum Work Area. This is a big milestone in laboratory diagnostics, as it can perform 2,200 tests every hour.
- February 2019 – Fujifilm Corporation and JEOL have formed a strategic partnership in the international clinical chemistry analyzer market.
Global Clinical Chemistry Market Scope
The clinical chemistry market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Clinical Chemistry Analysers
- POC Test Kits
- Clinical Chemistry Analyser Kits and Reagents
Application
- Basic Metabolite Panel
- Liver Function Test
- Electrolyte Panel
- Kidney Function Test
- Lipid Profile
- Specialty Chemical Test
- Thyroid Profile
- Other Biochemical Tests
End-User
- Hospitals
- Pathology Laboratories
- Maternity Centres
- Outpatient Centres
- Clinics
Clinical Chemistry Market Regional Analysis/Insights
The clinical chemistry market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the clinical chemistry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the clinical chemistry market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness and growing demand for advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Clinical Chemistry Market Share Analysis
The clinical chemistry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clinical chemistry market.
Some of the major players operating in the clinical chemistry market are:
- Abbott (US)
- Danaher (US)
- Thermo Fisher Scientific Inc.( US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Johnson & Johnson Services, Inc. (US)
- Siemens(Germany)
- ELI Tech Group (France)
- HORIBA, Ltd.( Japan)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
- Randox Laboratories Ltd. (United Kingdom)
- Ortho Clinical Diagnostics(US)
- Nova Biomedical (US)
- Sysmex Corporation (Japan)
- Bio Systems Diagnostics Pvt. Ltd. (India)
- DiaSys Diagnostic Systems GmbH (Germany)
- Endress Hauser Management AG (Switzerland)
- Diatron (Hungary)
- SFRI. (France)
- EKF Medica Corporation (UK)
SKU-